Literature DB >> 15549584

Multidisciplinary approach to cancer treatment: a model for breast cancer treatment at the M.D. Anderson Cancer Center.

Ryungsa Kim1, Tetsuya Toge.   

Abstract

Despite that fact that a multidisciplinary approach is important for cancer treatment, this approach is not widely used in Japan. The M.D. Anderson Cancer Center (MDACC) is one of the most well-established cancer institutes in the world, and has implemented a unique multidisciplinary team management approach for the treatment of breast cancer. The efforts of MDACC to eliminate cancer have been ongoing for more than 60 years. Here, we describe the multidisciplinary approach used at MDACC for the treatment for breast cancer. We focus on the background of the institute, in terms of establishing its treatment model and educational system, and compare its multidisciplinary approach with the current approach used in Japan, in the hopes of influencing future directions in cancer therapy in Japan.

Entities:  

Mesh:

Year:  2004        PMID: 15549584     DOI: 10.1007/s10147-004-0411-7

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  3 in total

1.  Multidisciplinary cancer conferences: exploring obstacles and facilitators to their implementation.

Authors:  Nicole J Look Hong; Anna R Gagliardi; Susan E Bronskill; Lawrence F Paszat; Frances C Wright
Journal:  J Oncol Pract       Date:  2010-03       Impact factor: 3.840

2.  Coordinating cancer care: patient and practice management processes among surgeons who treat breast cancer.

Authors:  Steven J Katz; Sarah T Hawley; Monica Morrow; Jennifer J Griggs; Reshma Jagsi; Ann S Hamilton; John J Graff; Christopher R Friese; Timothy P Hofer
Journal:  Med Care       Date:  2010-01       Impact factor: 2.983

3.  Adherence to hormone therapy among women with breast cancer.

Authors:  Claudia Brito; Margareth Crisóstomo Portela; Mauricio Teixeira Leite de Vasconcellos
Journal:  BMC Cancer       Date:  2014-06-03       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.